Skip to main content

Table 1 Details of the study population (21 cases of postcardiotomy extracorporeal membrane oxygenation)

From: Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation

Case

Age

Weight (kg)

ECMO implant site

CPB duration (minutes)

ECMO duration (hours)

Thrombotic complications

Anticoagulant

Outcome

1

Adult

105

OR

498

50

None

Heparin

Dead on ECMO

2

Adult

66

OR

322

170

None

Heparin

Dead on ECMO

3

Adult

100

OR

118

40

None

Heparin

Survived

4

Infant

2.9

OR

115

124

None

Heparin

Dead on ECMO

5

Child

15

OR

74

40

None

Heparin

Survived

6

Infant

3.6

ICU

125

110

None

Heparin

Weaned and dead

7

Newborn

2.7

OR

273

90

None

Heparin

Dead on ECMO

8

Newborn

3

ICU

317

16

None

Heparin

Dead on ECMO

9

Child

45

ICU

150

234

None

Bivalirudin

Dead on ECMO

10

Adult

60

ICU

73

88

None

Bivalirudin

Weaned and dead

11

Adult

74

OR

221

135

None

Bivalirudin

Survived

12

Adult

95

OR

180

39

None

Bivalirudin

Dead on ECMO

13

Adult

76

ICU

345

262

None

Bivalirudin

Weaned and dead

14

Adult

85

OR

198

233

None

Bivalirudin

Dead on ECMO

15

Adult

65

OR

442

69

None

Bivalirudin

Survived

16

Adult

75

OR

402

190

None

Bivalirudin

Weaned and dead

17

Adult

65

OR

315

67

None

Bivalirudin

Weaned and dead

18

Infant

7

ICU

85

175

None

Bivalirudin

Weaned and dead

19

Newborn

3.3

OR

255

110

None

Bivalirudin

Survived

20

Infant

7.6

OR

266

168

Yes

Bivalirudin

Weaned and dead

21

Newborn

2.6

OR

559

87

None

Bivalirudin

Dead on ECMO

  1. CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; OR, operating room.